Asaad Khalid

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Alize J Ferrari, Damian Santomauro, Amirali Aali et al. · The Lancet · 2024 · 3.7K citations · Full text

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

Hazim Ababneh, Yohannes Habtegiorgis Abate, Cristiana Abbafati et al. · The Lancet · 2024 · 790 citations · Full text

Global Burden, Infectious Disease Epidemiology, Forecasting Analysis +13

Juliflorine: A potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer’s disease therapy

M. Iqbal Choudhary, Sarfraz Ahmad Nawaz, Zaheer Ul‐Haq et al. · Biochemical and Biophysical Research Communications · 2005 · 97 citations

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +8

Presence of cholinomimetic and acetylcholinesterase inhibitory constituents in betel nut

Anwarul Hassan Gilani, Muhammad Nabeel Ghayur, Zafar Saied Saify et al. · Life Sciences · 2004 · 89 citations

Pharmacology, Nutraceutical Ingredient, Betel Nut +1

Acetyl and butyrylcholinesterase-inhibiting triterpenoid alkaloids from Buxus papillosa

Atta‐ur Rahman, Shehnaz Parveen, Asaad Khalid et al. · Phytochemistry · 2001 · 84 citations

Butyrylcholinesterase-inhibiting Triterpenoid Alkaloids, Medicinal Chemistry, Biochemistry +4